GRIECO, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 7.733
EU - Europa 6.591
NA - Nord America 6.277
SA - Sud America 1.160
AF - Africa 188
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 11
Totale 21.971
Nazione #
US - Stati Uniti d'America 5.973
SG - Singapore 4.261
RU - Federazione Russa 3.123
CN - Cina 1.737
IT - Italia 1.123
BR - Brasile 958
HK - Hong Kong 721
VN - Vietnam 519
DE - Germania 416
FI - Finlandia 340
UA - Ucraina 315
IE - Irlanda 271
NL - Olanda 265
SE - Svezia 220
GB - Regno Unito 213
CA - Canada 183
FR - Francia 100
IN - India 97
AR - Argentina 81
MX - Messico 76
BD - Bangladesh 58
ZA - Sudafrica 58
PL - Polonia 53
TR - Turchia 52
CI - Costa d'Avorio 51
KR - Corea 47
ES - Italia 42
JP - Giappone 38
EC - Ecuador 34
ID - Indonesia 30
IQ - Iraq 28
BE - Belgio 24
IR - Iran 22
CO - Colombia 21
PK - Pakistan 20
AT - Austria 19
PY - Paraguay 19
MA - Marocco 18
SA - Arabia Saudita 14
LT - Lituania 13
UY - Uruguay 13
BG - Bulgaria 12
CL - Cile 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 10
UZ - Uzbekistan 10
EU - Europa 9
IL - Israele 9
PE - Perù 9
CZ - Repubblica Ceca 8
DZ - Algeria 8
HN - Honduras 8
EG - Egitto 7
JM - Giamaica 7
KE - Kenya 7
NP - Nepal 7
TT - Trinidad e Tobago 7
AU - Australia 6
AZ - Azerbaigian 6
PA - Panama 6
ET - Etiopia 5
GT - Guatemala 5
JO - Giordania 5
KZ - Kazakistan 5
MK - Macedonia 5
NZ - Nuova Zelanda 5
AF - Afghanistan, Repubblica islamica di 4
BY - Bielorussia 4
LB - Libano 4
PS - Palestinian Territory 4
SN - Senegal 4
TN - Tunisia 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
CH - Svizzera 3
HU - Ungheria 3
KG - Kirghizistan 3
KH - Cambogia 3
PH - Filippine 3
RO - Romania 3
TJ - Tagikistan 3
BH - Bahrain 2
BW - Botswana 2
BZ - Belize 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GA - Gabon 2
LY - Libia 2
MD - Moldavia 2
ML - Mali 2
MZ - Mozambico 2
OM - Oman 2
PT - Portogallo 2
SV - El Salvador 2
TH - Thailandia 2
TZ - Tanzania 2
UG - Uganda 2
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
Totale 21.942
Città #
Singapore 1.860
Moscow 755
Chandler 720
Hong Kong 716
Beijing 548
Ashburn 441
Naples 354
Santa Clara 329
Jacksonville 311
Hefei 297
Amsterdam 242
Princeton 220
Millbury 215
Los Angeles 201
Dallas 184
Ho Chi Minh City 167
Boston 163
Nanjing 163
Napoli 147
Buffalo 124
São Paulo 115
Munich 102
New York 101
Wilmington 99
Ottawa 97
The Dalles 90
Hanoi 89
Dong Ket 78
Des Moines 77
Redondo Beach 76
Woodbridge 70
Houston 69
Turku 55
Ann Arbor 53
Helsinki 49
Nanchang 47
Warsaw 47
Seattle 46
Seoul 44
Shenyang 41
Brooklyn 39
Frankfurt am Main 37
Chicago 36
Denver 36
Mexico City 36
San Jose 36
Norwalk 35
Rome 35
Rio de Janeiro 33
Stockholm 33
Falkenstein 32
Poplar 31
Montreal 30
Hebei 29
Jiaxing 29
London 29
Kronberg 27
Milan 27
Changsha 26
Nuremberg 26
Tokyo 26
Toronto 26
Dublin 25
Johannesburg 25
Lawrence 25
Orem 25
Tianjin 25
North Bergen 24
Atlanta 23
Boardman 23
Lappeenranta 23
Chennai 20
Biên Hòa 19
Düsseldorf 19
Phoenix 19
Dearborn 18
Da Nang 17
Brasília 16
Columbus 16
Hangzhou 16
Belo Horizonte 15
Manchester 15
Charlotte 14
Falls Church 14
Porto Alegre 14
Brussels 13
Buenos Aires 13
Caserta 13
Haiphong 13
Ankara 12
Arce 12
Guangzhou 12
Hải Dương 12
Querétaro 12
San Francisco 12
Curitiba 11
Guayaquil 11
Kunming 11
Salt Lake City 11
Asunción 10
Totale 10.924
Nome #
" Molecular Modelingof the Urotensin-II receptor Complex" 216
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides 202
Antimicrobial peptide Temporin-L complexed with anionic cyclodextrins results in a potent and safe agent against sessile bacteria 163
Screening Platform toward New Anti-HIV Aptamers Set on Molecular Docking and Fluorescence Quenching Techniques 162
Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration 157
Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta 148
Microwave-Assisted Synthesis of 2-Methyl-1H-indole-3-carboxylate Derivatives via Pd-Catalyzed Heterocyclization 141
Unraveling the active conformation of urotensin II 141
Unveiling the mechanism of action of acylated temporin L analogues against multidrug-resistant Candida albicans 138
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 137
An investigation into the origin of the biased agonism associated with the urotensin II receptor activation 135
Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs 132
Cyclization of the urokinase receptor-derived Ser-Arg-Ser-Arg-Tyr peptide generates a potent inhibitor of trans-endothelial migration of monocytes 132
"3D Structural analysis of Urotensin-II analogues in membrane mimetic environment" 129
Discovery of New Potent Ligands at Human Urotensin-II Receptor 129
Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities 128
Novel Antimicrobial Peptide from Temporin L in The Treatment of Staphylococcus pseudintermedius and Malassezia pachydermatis in Polymicrobial Inter-Kingdom Infection 125
The Outcomes of Decorated Prolines in the Discovery of Antimicrobial Peptides from Temporin-L 124
Synthesis and Pharmacological Evaluation of a Novel Peptide Based on Anemonia sulcata BDS-I Toxin as a New KV3.4 Inhibitor Exerting a Neuroprotective Effect Against Amyloid-β Peptide 123
Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor 122
Antifungal and Antibiofilm Activity of Cyclic Temporin L Peptide Analogues against Albicans and Non-Albicans Candida Species 121
Urotensin II(4-11) Azasulfuryl Peptides: Synthesis and Biological Activity 121
Synthesis of novel lignan-like compounds and their antimicrobial activity 121
Synthesis, biological activity and conformational study of 1,4-benzoxazine dderivatives as potassium channel modulators. 120
Unlocking the potential of protein-derived peptides to target G-quadruplex DNA: from recognition to anticancer activity 119
Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage 119
The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells 117
Short PlGF-derived peptides bind VEGFR-1 and VEGFR-2 in vitro and on the surface of endothelial cells 117
In vitro effects of protein fractions from Controne beans (Phaseolus vulgaris L. ecotype Controne) on intestinal permeability, ACE and α-amylase activities 117
Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position9 116
Phenol derived CVFM analogs inhibitors of ras farnesyl transferase possessing cellular in vitro activity. 114
Synthesis and in vitro activities of NK-1 antagonists derived from L-Triptophan. 114
Novel and Selective avb3 Receptor Peptide Antagonist: Design, Synthesis, and Biological Behavior 114
D-Amino Acids Containing Temporin L Analogues 114
Synthesis and Binding Affinities for 5-HT1A, 5-HT2A and 5-HT2C receptors of a series of 1- and 2-(4-arylpiperazinylalkyl)-4-(benzoyl)-1,2,3-triazole derivatives. 113
Novel approach to the synthesis of diaza-bridged heterocycle derivative. 113
Improved synthesis on solid phase of dithiocarbamic cRGD-derivative and 99m Tc-radiolabelling 113
Antimicrobial Activity of a Lipidated Temporin L Analogue against Carbapenemase-Producing Klebsiella pneumoniae Clinical Isolates 113
Design, synthesis, and conformational analysis of Melanotropin analogues of MTII and SHU9119. 112
The Anemonia sulcata Toxin BDS-I Protects Astrocytes Exposed to Aβ1–42 Oligomers by Restoring [Ca2+]i Transients and ER Ca2+ Signaling 112
Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells 111
A structure – activity relationship study on position –2 of the Gas C-terminal peptide able to inhibit Gs activation by A2A adenosine receptor. 110
Novel α-MSH peptide analogues with broad spectrum antimicrobial activity. 110
Investigation on side-product formation during the synthesis of a lactoferrin-derived lactam-bridged cyclic peptide 110
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion 109
Lead Optimization of P5U and Urantide: Discovery of Novel Potent Ligands at the Urotensin-II Receptor 108
Temporin L-derived peptide as a regulator of the acute inflammatory response in zymosan-induced peritonitis 108
Biophysical and biochemical characterization of a liposarcoma-derived recombinant MnSOD protein acting as an anticancer agent 107
Urantide Conformation and Interaction with the Urotensin-II Receptor 107
Synthesis and antinociceptive Activity of Peptides Related to Interleukin-1b193-195 Lys-Pro-Thr. 105
Breast tumor cell invasion and pro-invasive activity of cancer-associated fibroblasts co-targeted by novel urokinase-derived decapeptides 105
Ad-hoc modifications of cyclic mimetics of SOCS1 protein: Structural and functional insights 104
Synthesis and pharmacologi-cal activity of 2-(substituted)-3-{2-[(4-phenyl-4-cyano)piperidino]ethyl}-1,3-thiazolidin-4-ones. 104
SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors 104
Synthetic Amphipathic β-Sheet Temporin-Derived Peptide with Dual Antibacterial and Anti-Inflammatory Activities 103
Potential Functional Snacks: Date Fruit Bars Supplemented by Different Species of Lactobacillus spp 103
Synthesis of new pyrido[4,3-g and 3,4-g]quinoline-5,10-dione and dihydro thieno[[2,3-g and 3,2-g]quinoline-4,9-dione derivatives and perliminary evaluation of cytotoxic activity 103
Formulazione liquida micronizzabile per il trattamento terapeutico dell'acne e di altre patologie cutanee correlate 103
A new therapeutic approach to erectile dysfunction: Urotensin-II receptor high affinity agonist ligands 103
Chemical modifications in the seed region of miRNAs 221/222 increase the silencing performances in gastrointestinal stromal tumor cells 103
Design, Synthesis, and Cytotoxic Evaluation of AcylDerivatives of 3-Aminonaphtho[2,3-b]thiophene-4,9-dione, a Quinone-Based System 102
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors 102
Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage Polarization 102
The IkB Kinase Inhibitor, NEMO-binding Domain Peptide, inhibits rat balloon injury-induced neointimal formation. 101
Urotensin II: A Novel Target in Human Corpus Cavernosum 100
Design, Synthesis, and Evaluation of Gluten Peptide Analogs as Selective 401 Inhibitors of Human TG2 100
New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide. 100
NMR analysis of synthetic peptides agonist to PTPRJ, a receptor-type protein tyrosine phosphatase with tumor suppressor activity 100
NEW INSIGHT INTO THE BINDING MODE OF CYCLIC MELANOCORTIN LIGANDS AT THE MC4 RECEPTOR 100
Boosting Fmoc Solid-Phase Peptide Synthesis by Ultrasonication 100
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 100
Design and synthesis of the small libraries of peptidomimetics based on thiazolidine moiety 99
Synthesis, Biological Activity and Conformational Study of 1,4-Benzoxazine Derivatives as Potassium Channel Modulators 99
Design, Synthesis, and Conformational Analysis of Melanotropin Analogues of MTII and SHU9119 99
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 99
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 99
Unveiling the interaction between DNA G-quadruplexes and RG-rich peptides 99
Characterization of KRAS Mutational Regression in Oligometastatic Patients 98
Cross-talk between fmlp and αvβ5 receptors triggered by urokinase receptor-derived SRSRY peptide 98
Development of Cyclic Peptide Inhibitors of GRK2 98
null 98
Peptide functionalization of silicon for detection and classification of prostatic cells 98
Expanding Structure-Activity Relationships of Human Urotensin II Peptide Analogues: A Proposed Key Role of the N-Terminal Region for Novel Urotensin II Receptor Modulators 97
Design and Synthesis of Spirotryprostatin-inspired Diketopiperazine Systemsfrom Prolyl Spirooxoindolethiazolidine Derivatives 97
Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures 97
Binding site of loperamide: automated docking of loperamide in human mi - and delta -opioid receptors. 96
HOST DEFENSE TEMPORIN 1 PEPTIDES AND THEIR POTENTIAL AS ANTIVIRAL AGENTS 96
Synthesis of novel indol-based ring systems by acid-catalyzed condensation from -amino aldehydes and L-Trp-OMe 95
Synthesis and Pharmacological Evaluation of Analogs of Indole-Based Cannabimimetic Agents. 95
A novel quinone–based derivative (DTNQ-Pro) induces apoptotic death via modulation/reduction of hsp expression in a human colon adenocarcinoma cell line 95
Unraveling the active conformation of urotensin II 95
Structure-Activity Relationship, Conformational and Biological Studies of Temporin L Analogues 95
Discovery of a new class of triazole based inhibitors of acetyl transferase KAT2A 94
A novel route to synthesize Freidinger lactams by microwave irradiation 94
Conformational study on cyclic melanocortin ligands and new insight into their binding mode at the MC4 receptor 94
Development of a liposome-based formulation for vitamin K1 nebulization on the skin 94
Activation of Melanocortin Receptors MC1 and MC5 Attenuates Retinal Damage in Experimental Diabetic Retinopathy 94
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans 94
Rationally designed α-conotoxin analogues maintained analgesia activity and weakened side effects 94
Melanocortin type 3 receptor null mice are refractory to the inhibitory actions of a selective receptor agonist in experimental acute inflammation 93
Totale 11.224
Categoria #
all - tutte 76.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.020


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021423 0 0 0 0 0 0 64 24 97 40 102 96
2021/20221.275 32 4 11 16 18 50 16 56 273 92 171 536
2022/20231.779 273 126 55 162 201 193 18 153 266 224 82 26
2023/20241.239 57 182 210 53 84 88 39 141 17 32 237 99
2024/20257.256 389 454 60 113 107 372 695 455 736 805 2.451 619
2025/20267.870 1.503 931 1.456 1.248 2.164 546 22 0 0 0 0 0
Totale 22.398